SuperworthARS Pharmaceuticals shares outstanding SPRY
Diluted shares outstanding, averaged over each quarter, from 2020.
- Latest quarter, to Jun 30, 2026
- 99.3M
- On a year earlier
- +1.0%
- more shares
ARS Pharmaceuticals had 99.3M diluted shares outstanding on average in Q2 FY26, the quarter to Jun 30, 2026.
That is 1.0% more than a year earlier, so each share owns a little less of the company.
Shares outstanding over time
Fiscal year by fiscal year
| Fiscal year | Shares, fourth quarter | Change |
|---|---|---|
| FY2025 | 99M | −4% |
| FY2024 | 102.8M | +7% |
| FY2023 | 96.1M | +42% |
| FY2022 | 67.8M | +93% |
| FY2021 | 35.1M | n/a |
Each fiscal year is the twelve months to its fourth quarter, shown as the fourth quarter's average share count.
Quarter by quarter
| Quarter | Ended | Shares outstanding | On a year earlier |
|---|---|---|---|
| Q2 FY26 | 99.3M | +1% | |
| Q1 FY26 | 99.3M | +1% | |
| Q4 FY25 | 99M | −4% | |
| Q3 FY25 | 98.8M | +2% | |
| Q2 FY25 | 98.4M | +2% | |
| Q1 FY25 | 98.1M | +2% | |
| Q4 FY24 | 102.8M | +7% | |
| Q3 FY24 | 97M | +2% | |
| Q2 FY24 | 96.8M | +2% | |
| Q1 FY24 | 96.5M | +2% | |
| Q4 FY23 | 96.1M | +42% | |
| Q3 FY23 | 95.6M | +211% |
What the shares outstanding tells you
Diluted shares outstanding, averaged over the period. Fewer shares means each one owns more of the company.
A falling count usually means buybacks. A rising one means stock pay, acquisitions paid in shares or new shares sold.
More on ARS Pharmaceuticals
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.